Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy

Immune checkpoint inhibitors (ICIs) have changed how we think about tumor management. Combinations of anti-programmed death ligand-1 (PD-L1) immunotherapy have become the standard of care in many advanced-stage cancers, including as a first-line therapy. Aside from improved anti-tumor immunity, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dora, David, Bokhari, Syeda Mahak Zahra, Aloss, Kenan, Takacs, Peter, Desnoix, Juliane Zsuzsanna, Szklenárik, György, Hurley, Patrick Deniz, Lohinai, Zoltan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916922/
https://www.ncbi.nlm.nih.gov/pubmed/36769093
http://dx.doi.org/10.3390/ijms24032769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916922/
https://www.ncbi.nlm.nih.gov/pubmed/36769093
http://dx.doi.org/10.3390/ijms24032769

Ejemplares similares